Sort
21,453 grants matching “tuberculosis”
Systems Biology for Molecular Analysis of Tuberculosis in Ethiopia
$206,567Gobena Ameni · Addis Ababa University · U01 · FY2015 · HG
Molecular mechanisms of TB exposure outcomes among HIV-infected children
$206,481Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2021 · AI
Immune Activation and Isoniazid Metabolism in HIV/TB
$206,473Gregory P. Bisson · University Of Pennsylvania · R21 · FY2014 · AI
Pharmacokinetics and Pharmacodynamics of Dolutegravir in Children Weighing â¥20 Kg Living with HIV with and without TB Coinfection
$206,434Awewura Jacob Kwara · University Of Florida · R21 · FY2022 · AI
Administrative Core
$206,276Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Gut Microbiome and Pharmacokinetic Variability in Tuberculosis and Diabetes
$206,267Navaneeth Narayanan · Rutgers Biomedical And Health Sciences · K23 · FY2025 · AI
MtrA and Mycobacterium tuberculosis proliferation
$206,250Malini Rajagopalan · University Of Texas Hlth Ctr At Tyler · R21 · FY2006 · AI
Elucidating the link between Mycobacterium tuberculosis potassium homeostasis and its lipid metabolism and growth in vivo
$206,250Shumin Tan · Tufts University Boston · R21 · FY2023 · AI
Metabolic compensation in Mycobacterium tuberculosis for the formation of persisters
$206,250Hyungjin Eoh · University Of Southern California · R21 · FY2020 · AI
The regulation of basal interferon and its role in necroptosis
$206,250Alexander Poltorak · Tufts University Boston · R21 · FY2016 · AI
Identification of Mycobacterium tuberculosis-derived metabolites acting as ligands for MR1-restricted T cells.
$206,200Charles Kyriakos Vorkas · State University New York Stony Brook · R21 · FY2024 · AI
Development of a transformative approach to the rapid detection, isolation, and i
$206,191Birgit Ursula Jaki · University Of Illinois At Chicago · R21 · FY2012 · AI
Practical Diagnostics for AIDS-Related Pediatric TB,Peru
$206,190Tulane University Of Louisiana · R01 · FY2002 · AI
Elemental imaging of M. tuberculosis during infection.
$206,054Adel M Talaat · University Of Wisconsin-Madison · R21 · FY2009 · AI
Pyruvate Dehydrogenase E1: Structure-Function Studies
$205,915William F Furey · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · GM
Kvbeta2 and the host response to cyclic dinucleotides
$205,874Joshua Woodward · University Of Washington · R21 · FY2022 · AI
Targetting InhA For Anti-TB Drug Discovery
$205,756Peter J Tonge · State University New York Stony Brook · R01 · FY2008 · AI
A Study of Heterologous Immunity Induced by Neonatal BCG Vaccination
$205,625Daniel H. Libraty · Univ Of Massachusetts Med Sch Worcester · R21 · FY2012 · AI
Enhancing TB vaccine with gene silencing
$205,625Jinhee Lee · Univ Of Massachusetts Med Sch Worcester · R21 · FY2012 · AI
A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway
$205,425Robert C Reynolds · University Of Alabama At Birmingham · R21 · FY2021 · AI
Tri-Institutional TRAC Clinical Science Core
$205,419Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · P30 · FY2023 · AI
Mycobacterium tuberculosis aerobiology and novel tools to assess infectiousness
$205,391David J. Horne · University Of Washington · UH2 · FY2021 · AI
Development of a method for visual detection of Mycobacterium tuberculosis complex
$205,317Yulia Gerasimova · University Of Central Florida · R21 · FY2017 · AI
Rifampin potentiation in NTM
$205,299Graham S Timmins · Spinceutica, Inc. · R41 · FY2020 · AI
Bridging adult to pediatric markers of tuberculosis disease severity
$205,289Lance A Liotta · George Mason University · R21 · FY2019 · HD